OBJECTIVE: To perform a systematic review of the published literature on disease management of rheumatoid arthritis (RA) and to use meta-analysis to estimate the magnitude of benefit these programs have on functional status in patients with RA. METHODS: Computerized databases for English articles from 1966 to September 2001 were searched. Two reviewers evaluated 1,029 published titles, identified 11 studies meeting explicit inclusion criteria, and extracted data about study characteristics, interventions used, and outcomes measured. Pooled effect sizes for functional status were calculated using a random-effects model. RESULTS: Four out of 8 disease management programs showed significant improvements in functional status; however, the pooled effect size (ES) was small and statistically non-significant (ES 0.27; 95% confidence interval [95% CI] -0.01, 0.54). Studies with longer intervention durations (>5 weeks) had significantly improved patient functional status (ES 0.49; 95% CI 0.12, 0.86), compared with studies with shorter intervention durations (</=5 weeks, ES 0.13; 95% CI -0.25, 0.52). CONCLUSIONS: There were limited data to support or refute the effectiveness of disease management programs in improving functional status in patients with RA. Additional studies are needed to confirm if a more intensive intervention may be of benefit to patients with RA, as suggested by our study.
OBJECTIVE: To perform a systematic review of the published literature on disease management of rheumatoid arthritis (RA) and to use meta-analysis to estimate the magnitude of benefit these programs have on functional status in patients with RA. METHODS: Computerized databases for English articles from 1966 to September 2001 were searched. Two reviewers evaluated 1,029 published titles, identified 11 studies meeting explicit inclusion criteria, and extracted data about study characteristics, interventions used, and outcomes measured. Pooled effect sizes for functional status were calculated using a random-effects model. RESULTS: Four out of 8 disease management programs showed significant improvements in functional status; however, the pooled effect size (ES) was small and statistically non-significant (ES 0.27; 95% confidence interval [95% CI] -0.01, 0.54). Studies with longer intervention durations (>5 weeks) had significantly improved patient functional status (ES 0.49; 95% CI 0.12, 0.86), compared with studies with shorter intervention durations (</=5 weeks, ES 0.13; 95% CI -0.25, 0.52). CONCLUSIONS: There were limited data to support or refute the effectiveness of disease management programs in improving functional status in patients with RA. Additional studies are needed to confirm if a more intensive intervention may be of benefit to patients with RA, as suggested by our study.
Authors: M Schneider; M Lelgemann; C Baerwald; J Braun; M Hammer; P Kern; A Krause; R Alten; U Faubel; M Hammer; J Lakomek; W Liman; Th Pauly; A Schnabel Journal: Z Rheumatol Date: 2004-10 Impact factor: 1.372
Authors: Manjari Lahiri; Peter P M Cheung; Preeti Dhanasekaran; Su-Ren Wong; Ai Yap; Daphne S H Tan; Siew-Hwa Chong; Chiew-Hwa Tan; Amelia Santosa; Phillip Phan Journal: Qual Life Res Date: 2021-11-06 Impact factor: 4.147
Authors: Myrthe van Vilsteren; Cécile R L Boot; Romy Steenbeek; Dirkjan van Schaardenburg; Alexandre E Voskuyl; Johannes R Anema Journal: BMC Public Health Date: 2012-07-02 Impact factor: 3.295
Authors: Cindy Noben; Myrthe van Vilsteren; Cécile Boot; Romy Steenbeek; Dirkjan van Schaardenburg; Johannes R Anema; Silvia Evers; Frans Nijhuis; Angelique de Rijk Journal: J Occup Health Date: 2017-04-05 Impact factor: 2.708
Authors: Melinde R S Boland; Apostolos Tsiachristas; Annemarije L Kruis; Niels H Chavannes; Maureen P M H Rutten-van Mölken Journal: BMC Pulm Med Date: 2013-07-03 Impact factor: 3.317
Authors: Nahara Anani Martínez-González; Peter Berchtold; Klara Ullman; André Busato; Matthias Egger Journal: Int J Qual Health Care Date: 2014-08-09 Impact factor: 2.038
Authors: Pedro Santos-Moreno; Paola Castillo; Laura Villareal; Carlos Pineda; Hugo Sandoval; Omaira Valencia Journal: Open Access Rheumatol Date: 2020-11-06